KIT and acute myeloid leukemia: Mutated KIT induces constitutive activation of phosphoinositide 3-kinase (PI3K)/AKT, ERK, and STAT3 pathways, and cooperates with RUNX1T1-RUNX1 to induce AML in mice23.